Treatment of Hyperemesis Gravidarum

Initial Stabilization and Assessment

Administer IV fluid resuscitation to correct dehydration, which often improves associated liver enzyme abnormalities, and replace electrolytes with particular attention to potassium and magnesium levels, as recommended by the American College of Obstetricians and Gynecologists 1
Start thiamine 100 mg daily for minimum 7 days, then 50 mg daily maintenance until adequate oral intake is established to prevent Wernicke encephalopathy, with a switch to IV thiamine 200-300 mg daily if vomiting persists or patient cannot tolerate oral intake 2, 1
Check electrolyte panel, liver function tests, and urinalysis for ketonuria, and assess severity using the Pregnancy-Unique Quantification of Emesis (PUQE) score, as recommended by the American College of Obstetricians and Gynecologists 2, 1
Perform abdominal ultrasonography to detect multiple or molar pregnancies and rule out hepatobiliary causes, as recommended by the American College of Obstetricians and Gynecologists 2

The American College of Obstetricians and Gynecologists recommends doxylamine-pyridoxine combination as the preferred initial antiemetic, safe throughout pregnancy and breastfeeding 1
Metoclopramide is the preferred second-line agent when first-line antihistamines fail, with similar efficacy to promethazine but fewer side effects, as reported in a randomized study comparing promethazine and metoclopramide in hospitalized patients 2
Ondansetron should be reserved as second-line therapy due to concerns about congenital heart defects when used before 10 weeks gestation, though recent data suggest the risk is low, and the American College of Obstetricians and Gynecologists recommends using ondansetron on a case-by-case basis before 10 weeks of pregnancy 1, 2
Methylprednisolone should be reserved as last resort for severe hyperemesis gravidarum that fails other therapies, with a specific dosing protocol and caution in the first trimester due to slight increased risk of cleft palate when given before 10 weeks gestation, as recommended by the American College of Obstetricians and Gynecologists 1

Severe cases require involvement of obstetricians, gastroenterologists, nutritionists, and mental health professionals for comprehensive management, as recommended by the American College of Obstetricians and Gynecologists and the American Gastroenterological Association 2, 1

Regular assessments should include hydration status, electrolyte balance, symptom control using PUQE score, fetal growth monitoring, and monthly fetal growth scans from viability in severe cases, as recommended by the American College of Obstetricians and Gynecologists 1, 2
Symptoms resolve by week 16 in >50% of patients and by week 20 in 80%, though 10% experience symptoms throughout pregnancy, with a recurrence risk in subsequent pregnancies of 40-92%, as reported in a study on the prognosis of hyperemesis gravidarum 2, 1
No significant efficacy difference exists among commonly used antiemetics (metoclopramide, ondansetron, promethazine) based on meta-analysis of 25 studies, so medication selection should be based on safety profile and gestational age, as recommended by the American College of Obstetricians and Gynecologists and the American Gastroenterological Association 2, 1

The European Association for the Study of the Liver specifically endorses phenothiazines (including promethazine) as first-line pharmacologic treatment for hyperemesis gravidarum 3, 4
Promethazine is an acceptable first-line antiemetic option for hyperemesis gravidarum, but metoclopramide is preferred when escalating beyond initial antihistamine therapy due to its superior side effect profile with equivalent efficacy 4
When escalating from first-line therapy, metoclopramide is the preferred second-line agent rather than continuing promethazine 4
In a head-to-head randomized trial of hospitalized hyperemesis gravidarum patients, promethazine and metoclopramide showed similar efficacy, but promethazine caused significantly more drowsiness, dizziness, dystonia, and treatment discontinuations due to adverse events compared to metoclopramide 3, 4

No increased risk of congenital defects has been reported with promethazine use 3
Extrapyramidal side effects can occur with phenothiazines—withdraw the drug immediately if these symptoms develop 3, 4

A Cochrane meta-analysis of 25 studies found no significant efficacy difference among commonly used antiemetics (metoclopramide, ondansetron, and promethazine) for hyperemesis gravidarum 3, 4
Medication selection should therefore be based on safety profile, side effect tolerance, and gestational age rather than efficacy alone, although this specific statement lacks a valid reference, the concept is supported by 3, 4

Escalate to metoclopramide (not additional promethazine) if first-line antihistamines fail 4
Reserve ondansetron as second-line therapy, using case-by-case before 10 weeks gestation due to potential congenital heart defect concerns 4
Use methylprednisolone (16 mg IV every 8 hours for up to 3 days, then taper) only as last resort for severe refractory cases 3, 4

Do not continue escalating promethazine doses when side effects emerge—switch to metoclopramide instead 4

The American College of Obstetricians and Gynecologists recommends ondansetron 8 mg orally every 8 hours for moderate to severe hyperemesis gravidarum, which can be given as oral dissolving tablet or oral soluble film at the same dose 5, 6
Alternative dosing for ondansetron is 16 mg orally as a single dose, then 8 mg twice daily 7
For intravenous administration, ondansetron can be given as 8 mg IV or 0.15 mg/kg IV as a single dose 5
For refractory cases, ondansetron can be administered as 8 mg IV bolus followed by 1 mg/hour continuous infusion 6